Skip to main content
Premium Trial:

Request an Annual Quote

Dalton Pharma to Use Thermo Fisher Tech for Biopolymers

NEW YORK (GenomeWeb News) – Dalton Pharma Services will use Thermo Fisher Scientific’s enzyme-based technology to make nucleic acid biopolymers for use in drug development research projects, Toronto-base Dalton said today.
 
Dalton will produce poly-inosine and poly-cytosine in accordance with current good manufacturing practice regulations.
 
These polynucleotides are used as catalysts to stimulate immune responses when they are combined with other substances in a drug, the company said.
 
Dalton also said it plans to supply these polynucleotides to the pharmaceutical company Oncovir, which will use them in vaccine development projects.
 
Financial terms of the agreement were not released.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.